Publication: Urinary Concentrations of Major Phthalate and Alternative Plasticizer Metabolites in Children of Thailand, Indonesia, and Saudi Arabia, and Associated Risks
2
Issued Date
2021-12-21
Resource Type
ISSN
15205851
0013936X
0013936X
Other identifier(s)
2-s2.0-85120891880
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Environmental Science and Technology. Vol.55, No.24 (2021), 16526-16537
Suggested Citation
Inae Lee, Claudia Pälmke, Benedikt Ringbeck, Yunchul Ihn, Alexandra Gotthardt, Gowoon Lee, Raid Alakeel, May Alrashed, Ramadhan Tosepu, Erwin Azizi Jayadipraja, Kraichat Tantrakarnapa, Wissanupong Kliengchuay, Younglim Kho, Holger M. Koch, Kyungho Choi Urinary Concentrations of Major Phthalate and Alternative Plasticizer Metabolites in Children of Thailand, Indonesia, and Saudi Arabia, and Associated Risks. Environmental Science and Technology. Vol.55, No.24 (2021), 16526-16537. doi:10.1021/acs.est.1c04716 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/76567
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Urinary Concentrations of Major Phthalate and Alternative Plasticizer Metabolites in Children of Thailand, Indonesia, and Saudi Arabia, and Associated Risks
Abstract
Phthalates are widely used in consumer products and are well-known for adverse endocrine outcomes. Di-(2-ethylhexyl) phthalate (DEHP), one of the most extensively used phthalates, has been rapidly substituted with alternative plasticizers in many consumer products. The aim of this study was to assess urinary phthalate and alternative plasticizer exposure and associated risks in children of three Asian countries with different geographical, climate, and cultural characteristics. Children were recruited from elementary schools of Saudi Arabia (n = 109), Thailand (n = 104), and Indonesia (n = 89) in 2017–2018, and their urine samples were collected. Metabolites of major phthalates and alternative plasticizers were measured in the urine samples by HPLC-MS/MS. Urinary metabolite levels differed substantially between the three countries. Metabolite levels of diisononyl phthalate (DiNP), diisodecyl phthalate (DiDP), di(2-ethylhexyl) terephthalate (DEHTP), and 1,2-cyclohexane dicarboxylic acid diisononyl ester (DINCH) were the highest in Saudi children: Median urinary concentrations of oxo-MiNP, OH-MiDP, 5cx-MEPTP, and OH-MINCH were 8.3, 8.4, 128.0, and 2.9 ng/mL, respectively. Urinary DEHP metabolite concentrations were the highest in the Indonesian children. The hazard index (HI) derived for the plasticizers with antiandrogenicity based reference doses (RfDAA) was >1 in 86%, 80%, and 49% of the Saudi, Indonesian, and Thai children, respectively. DEHP was identified as a common major risk driver for the children of all three countries, followed by DnBP and DiBP depending on the country. Among alternative plasticizers, urinary DEHTP metabolites were detected at levels comparable to those of DEHP metabolites or higher among the Saudi children, and about 4% of the Saudi children exceeded the health based human biomonitoring (HBM)-I value. Priority plasticizers that were identified among the children of three countries warrant refined exposure assessment for source identification and relevant exposure reduction measures.